These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 28980219)
1. Persistent Endocrine-Disrupting Chemicals and Fatty Liver Disease. Deierlein AL; Rock S; Park S Curr Environ Health Rep; 2017 Dec; 4(4):439-449. PubMed ID: 28980219 [TBL] [Abstract][Full Text] [Related]
2. Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. Cano R; Pérez JL; Dávila LA; Ortega Á; Gómez Y; Valero-Cedeño NJ; Parra H; Manzano A; Véliz Castro TI; Albornoz MPD; Cano G; Rojas-Quintero J; Chacín M; Bermúdez V Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062716 [TBL] [Abstract][Full Text] [Related]
3. Association between endocrine-disrupting chemical mixtures and non-alcoholic fatty liver disease with metabolic syndrome as a mediator among adults: A population-based study in Korea. Park B; Kim B; Kim CH; Oh HJ; Park B Ecotoxicol Environ Saf; 2024 May; 276():116310. PubMed ID: 38614002 [TBL] [Abstract][Full Text] [Related]
4. Biomonitoring and hormone-disrupting effect biomarkers of persistent organic pollutants in vitro and ex vivo. Bonefeld-Jørgensen EC; Ghisari M; Wielsøe M; Bjerregaard-Olesen C; Kjeldsen LS; Long M Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):118-28. PubMed ID: 24797035 [TBL] [Abstract][Full Text] [Related]
6. Effects of co-exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin and polychlorinated biphenyls on nonalcoholic fatty liver disease in mice. Shan Q; Huang F; Wang J; Du Y Environ Toxicol; 2015 Dec; 30(12):1364-74. PubMed ID: 24861470 [TBL] [Abstract][Full Text] [Related]
7. Endocrine disrupting chemicals: A promoter of non-alcoholic fatty liver disease. Chen Y; Wang Y; Cui Z; Liu W; Liu B; Zeng Q; Zhao X; Dou J; Cao J Front Public Health; 2023; 11():1154837. PubMed ID: 37033031 [TBL] [Abstract][Full Text] [Related]
8. The association between endocrine disrupting chemicals and nonalcoholic fatty liver disease: A systematic review and meta-analysis. Pan K; Xu J; Xu Y; Wang C; Yu J Pharmacol Res; 2024 Jul; 205():107251. PubMed ID: 38862070 [TBL] [Abstract][Full Text] [Related]
10. Compound- and sex-specific effects on programming of energy and immune homeostasis in adult C57BL/6JxFVB mice after perinatal TCDD and PCB 153. van Esterik JC; Verharen HW; Hodemaekers HM; Gremmer ER; Nagarajah B; Kamstra JH; Dollé ME; Legler J; van der Ven LT Toxicol Appl Pharmacol; 2015 Dec; 289(2):262-75. PubMed ID: 26415833 [TBL] [Abstract][Full Text] [Related]
11. Exposure of pregnant women to persistent organic pollutants and cord sex hormone levels. Warembourg C; Debost-Legrand A; Bonvallot N; Massart C; Garlantézec R; Monfort C; Gaudreau E; Chevrier C; Cordier S Hum Reprod; 2016 Jan; 31(1):190-8. PubMed ID: 26493407 [TBL] [Abstract][Full Text] [Related]
12. Sex, Nutrition, and NAFLD: Relevance of Environmental Pollution. Dolce A; Della Torre S Nutrients; 2023 May; 15(10):. PubMed ID: 37242221 [TBL] [Abstract][Full Text] [Related]
13. Endocrine Disruptors and Developmental Origins of Nonalcoholic Fatty Liver Disease. Treviño LS; Katz TA Endocrinology; 2018 Jan; 159(1):20-31. PubMed ID: 29126168 [TBL] [Abstract][Full Text] [Related]
14. Human epidemiological evidence about the associations between exposure to organochlorine chemicals and endometriosis: Systematic review and meta-analysis. Cano-Sancho G; Ploteau S; Matta K; Adoamnei E; Louis GB; Mendiola J; Darai E; Squifflet J; Le Bizec B; Antignac JP Environ Int; 2019 Feb; 123():209-223. PubMed ID: 30530163 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Environmental Contributions to Fatty Liver Disease. Wahlang B; Jin J; Beier JI; Hardesty JE; Daly EF; Schnegelberger RD; Falkner KC; Prough RA; Kirpich IA; Cave MC Curr Environ Health Rep; 2019 Sep; 6(3):80-94. PubMed ID: 31134516 [TBL] [Abstract][Full Text] [Related]
16. The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease. Polyzos SA; Kountouras J; Deretzi G; Zavos C; Mantzoros CS Curr Mol Med; 2012 Jan; 12(1):68-82. PubMed ID: 22082482 [TBL] [Abstract][Full Text] [Related]
17. Toxicology and carcinogenesis studies of 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (CAS No. 31508-00-6) in female harlan Sprague-Dawley rats (gavage studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2010 Nov; (559):1-174. PubMed ID: 21383778 [TBL] [Abstract][Full Text] [Related]
18. Effects of environmental contaminants in water resources on nonalcoholic fatty liver disease. Zheng S; Yang Y; Wen C; Liu W; Cao L; Feng X; Chen J; Wang H; Tang Y; Tian L; Wang X; Yang F Environ Int; 2021 Sep; 154():106555. PubMed ID: 33857709 [TBL] [Abstract][Full Text] [Related]
19. Persistent organic pollutants and hyperuricemia in the U.S. general population. Lee YM; Bae SG; Lee SH; Jacobs DR; Lee DH Atherosclerosis; 2013 Sep; 230(1):1-5. PubMed ID: 23958244 [TBL] [Abstract][Full Text] [Related]
20. White adipose tissue: storage and effector site for environmental pollutants. Müllerová D; Kopecký J Physiol Res; 2007; 56(4):375-382. PubMed ID: 16925464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]